Connection
Siva Uppalapati to Antibodies, Bacterial
This is a "connection" page, showing publications Siva Uppalapati has written about Antibodies, Bacterial.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.217 |
|
|
|
-
Uppalapati SR, Kingston JJ, Murali HS, Batra HV. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein. Vaccine. 2014 May 23; 32(25):3075-81.
Score: 0.114
-
Singh K, Singh AK, Uppalapati SR, Kingston JJ, Parida M. Immunogenicity and protective efficacy of Burkholderia pseudomallei BLF1-N and BLF1-C terminal domains against BLF1 toxin. Int Immunopharmacol. 2019 Dec; 77:105917.
Score: 0.042
-
Chitradevi ST, Kaur G, Uppalapati S, Yadav A, Singh D, Bansal A. Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection. Cell Mol Immunol. 2015 Nov; 12(6):757-67.
Score: 0.030
-
Shreya D, Uppalapati SR, Kingston JJ, Sripathy MH, Batra HV. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model. Mol Immunol. 2015 May; 65(1):51-7.
Score: 0.030